How can I access the WIPO Sequence Tool?
The WIPO Sequence Tool is freely available for download from the WIPO website. According to MPEP 2418: This tool is downloadable, free of charge, from the WIPO website. The current version of WIPO Sequence is accessible at www.wipo.int/standards/en/sequence/index.html. Users can download and install the tool to become familiar with its dual functionalities of authoring and…
Read MoreHow should gaps in nucleotide sequences be represented in WIPO ST.25 format?
How should gaps in nucleotide sequences be represented in WIPO ST.25 format? According to MPEP 2423, gaps in nucleotide sequences should be represented using a specific symbol in WIPO ST.25 format: “Gaps of indeterminate length in the sequence must be represented by a series of the lower case letter “n”, the number of “n” residues…
Read MoreWhat are the format requirements for sequence listings in patent applications?
The format requirements for sequence listings in patent applications are specified in MPEP 2421.02 and 37 CFR 1.821-1.825. Key format requirements include: Sequence listings must be in a separate part of the disclosure. They should be presented in the standard sequence listing format. The listing must be readable by both humans and computers. It must…
Read MoreCan extrinsic evidence be used to support inherency in patent applications?
Can extrinsic evidence be used to support inherency in patent applications? Yes, extrinsic evidence can be used to support inherency in patent applications, but there are specific guidelines for its use. According to MPEP 2163.07(a): “Extrinsic evidence may be used to support inherency; however, extrinsic evidence must make clear that the missing descriptive matter is…
Read MoreAre there exceptions to the requirement for making a replacement deposit?
Yes, there are exceptions to the requirement for making a replacement deposit. According to MPEP 2407.03: “The provisions of 37 CFR 1.805(g) indicate that a replacement need not be made where, at the point in time when replacement would otherwise be necessary, access to the necessary biological material was otherwise available.” This means that if…
Read MoreIs evidence required to show that a deposited biological material can perform its described function?
Generally, no specific evidence is required to show that a deposited biological material can perform its described function in a patent application. According to MPEP 2409: “For the purpose of making a deposit under these rules, there is no requirement that evidence be provided that the deposited material is capable or has the ability to…
Read MoreHow is inherency established in patent applications?
Establishing inherency in patent applications requires clear evidence that the undisclosed feature is necessarily present in the invention. According to MPEP 2163.07(a): “To establish inherency, the extrinsic evidence ‘must make clear that the missing descriptive matter is necessarily present in the thing described in the reference, and that it would be so recognized by persons…
Read MoreWhat is the relationship between enablement and claim breadth in patent applications?
What is the relationship between enablement and claim breadth in patent applications? The relationship between enablement and claim breadth is crucial in patent applications. According to MPEP 2164.08, “The scope of the claims must be less than or equal to the scope of the enablement.” This means: The claims must be supported by the disclosure…
Read MoreHow are sequence listings submitted electronically for patent applications?
How are sequence listings submitted electronically for patent applications? Electronic submission of sequence listings for patent applications is the preferred method according to MPEP 2420. The process involves: Preparing the sequence listing in compliance with WIPO Standard ST.25. Submitting the sequence listing as a separate text file (*.txt). Ensuring the file is encoded in ASCII…
Read MoreWhat is the significance of the “effectively filed” date in 35 U.S.C. 102(a)(2)?
The “effectively filed” date is crucial for determining whether a reference qualifies as prior art under 35 U.S.C. 102(a)(2). The MPEP explains: “Even if the issue or publication date of the reference is not before the effective filing date of the claimed invention, the reference may still be applicable as prior art under 35 U.S.C.…
Read More